Cargando…
Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Medical Sciences
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110259/ https://www.ncbi.nlm.nih.gov/pubmed/35578591 http://dx.doi.org/10.3346/jkms.2022.37.e161 |
| _version_ | 1784709064367800320 |
|---|---|
| author | Finsterer, Josef |
| author_facet | Finsterer, Josef |
| author_sort | Finsterer, Josef |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9110259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Academy of Medical Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91102592022-05-23 Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 Finsterer, Josef J Korean Med Sci Correspondence The Korean Academy of Medical Sciences 2022-05-10 /pmc/articles/PMC9110259/ /pubmed/35578591 http://dx.doi.org/10.3346/jkms.2022.37.e161 Text en © 2022 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Finsterer, Josef Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title | Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title_full | Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title_fullStr | Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title_full_unstemmed | Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title_short | Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19 |
| title_sort | immunodeficiency should be excluded in patients with recurrent viral meningitis and breakthrough covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110259/ https://www.ncbi.nlm.nih.gov/pubmed/35578591 http://dx.doi.org/10.3346/jkms.2022.37.e161 |
| work_keys_str_mv | AT finstererjosef immunodeficiencyshouldbeexcludedinpatientswithrecurrentviralmeningitisandbreakthroughcovid19 |